Erbitux 5 Cetuximab Injection

About Erbitux 5 Cetuximab Injection

Erbitux Injection contains Cetuximab, a monoclonal antibody used in the treatment of specific types of cancers. It works by targeting the epidermal growth factor receptor (EGFR) on cancer cells, thereby inhibiting tumor cell growth and proliferation. Erbitux is widely used as part of targeted cancer therapy under strict medical supervision.

• Metastatic colorectal cancer (EGFR-expressing, KRAS wild-type)

• Squamous cell carcinoma of the head and neck

• Used alone or in combination with chemotherapy or radiotherapy

• Targeted monoclonal antibody therapy

• Specifically inhibits EGFR-mediated cancer cell growth

• Helps improve treatment response and disease control

• Clinically proven and globally trusted oncology product

• Dosage and schedule are decided by the oncologist

• Administered via intravenous infusion in a hospital or clinical setting

• Pre-medication may be required to reduce infusion reactions

• Prescription medicine only

• Use strictly under medical supervision

• Possible side effects include skin reactions, infusion reactions, low magnesium levels, and gastrointestinal disturbances

• Not recommended during pregnancy unless clearly advised by a physician